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sex differences in creatine levels have been found in the prefrontal cortex. It is however not 23 known to what degree these sex differences are stable or change with varying gonadal hormone 24 levels. The current study therefore investigated creatine in the prefrontal cortex across the 25 menstrual cycle. In addition, we explored cerebral asymmetries. Creatine, Choline (Cho), N-26 acetylaspartate (NAA), Myo inositol (mI), and glutamate+glutamine (Glx) were assessed three 27 times in 15 women and 14 men using MRS. Women were tested in cycle phases of varying 28 hormone levels (menstrual, follicular, and luteal phase). Prefrontal creatine was found to change 29 across the menstrual cycle, in a hemisphere-specific manner. Women in the follicular phase 30 showed increased left prefrontal creatine accompanied with reduced right prefrontal creatine, 31 while this asymmetry was not present in the luteal phase. In men, the creatine levels remained 32 stable across three testing sessions. In general, both men and women were found to have higher 
58
In the human brain the creatine levels can be assessed by proton magnetic resonance 59 
spectroscopy ( 1 H MRS). MRS is a non-invasive technique for obtaining in-vivo spectral

63
Creatine is often used as a reference compound in MRS studies, incorporated as the denominator 
68
In the human brain, there is evidence of sex differences in creatine levels in the prefrontal Quality control of the spectra was conducted and resulted in the identification of two poor 196 spectra, belonging to two different subjects; all spectra from these subjects were excluded from Table S1 . Correlations between hormones and creatine
251
For descriptive purposes scatter plots of correlation between the different sex hormones 252 measured (estradiol, testosterone, and progesterone) and creatine asymmetry were included (see 
266
Creatine asymmetries
267
In line with our hypothesis, overall higher creatine levels were found in the left as A leftward asymmetry was also observed for the metabolites NAA, Cho, and mI, but not 300 for GLX (see Table S1 ). The results are partly consistent with a previous study (Maudsley et al., to women. The current study could not replicate previous sex differences and found creatine 317 asymmetry to fluctuate across the menstrual cycle. Thus, the study suggests that sex differences
318
shown in previous studies are not invariant, but rather changes across the menstrual cycle with 319 fluctuating sex-hormone levels (state dependent), and sex differences would partly depend on the 320 cycle phase in which women are tested. In this regard the strength of the current study is 
337
The regional dependency, that is the change of creatine asymmetry across the menstrual cycle, in the follicular phase in the current study.
374
An obvious question that arises is why the asymmetry was reduced in the luteal phase.
375
The only hormone that was significantly different between the follicular and luteal phase is 376 progesterone. However, progesterone levels alone were not found related to creatine symmetry. 
Implications
385
The traditional MRS methodology of using creatine as a standard control measure has 386 been questioned (Rae, 2014) , partly because creatine has been found to not be as stable as should take sex and sex hormonal state into account when using creatine levels as a reference 392 measure. It should be noted that men showed relatively stable creatine levels across three testing 393 sessions and could arguably be used as a reference in male subjects. However, it should be tested 394 whether varying testosterone levels in men (e.g. across the diurnal cycle) influence creatine 395 concentration.
396
The findings of the current study also have clinical relevance since theories of impaired of Cho across the menstrual cycle (see Table S1 in supplementary material) depending on the luteal phase with even higher levels of estradiol in addition to high levels of progesterone.
417
Cho is a measure of membrane metabolism or turnover, and changes in the Cho resonance creatine. However, we cannot exclude the possibility that the increase in creatine production is a 438 result of an sex-hormonal modulation of the cholinergic system which might in turn change the 439 neuronal activity and the cellular energy demand.
440
Limitations
441
The current study was carefully controlled in terms of hormone measures and inclusion of 442 a male control group. Still, some limitations need to be considered. As already mentioned, the 443 sample size might be an issue when it comes to the detection of significant correlations between 444 hormones and creatine. The sample size also limits the number of regressors, and interaction 445 effects among hormones were therefore not explored. Further, the voxels could arguably have 446 been placed further lateral in order to cover more gray matter, and been limited to one 447 functionally specific region (e.g. IFG).
448
Although voxel segmentation into tissue classes was performed using standard software
449
(SPM8), we acknowledge that limitations of the segmentation method used may ultimately limit Randa, who assisted the data collection. The study was supported by grants from the Bergen Phase/Session, and Hemisphere (indicated with ^) was found (F(2,54)=3.77, p=0.03, η 2 =0.12). Post hoc testing revealed that the interaction was driven by differences in Cho concentration between the female cycle phases. More specifically there was a difference between the left and right hemisphere in the follicular phase (p<0.001) only. It should also be noted that when women are not compared against the male control groups, a menstrual cycle effect (Cycle Phase x Hemisphere) is also found in Glx (F =3.44, p=0.05, η 2 =0.2) driven by higher GLX in follicular phase than luteal phase in the left hemisphere (p=.01) and higher luteal GLX in right as compared to left hemisphere. For statistics for Cre and voxel GM content, see manuscript. The effect sizes (partial eta squared) reported in the table is from a lower level ANOVA conducted separately for women and men (interaction of Cycle Phase x Hemisphere in women, and Session x Hemisphere in men). 
